Olaplex Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $425.4M+0.6% YoYTTM through 31 Mar 2026
Net Income -$15M-176.9% YoYTTM through 31 Mar 2026
Free Cash Flow $68.6MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 69.4% |
| EBITDA Margin | 5.4% |
| Operating Margin | 1.6% |
| Net Margin | -3.5% |
Returns
-1.1%ROE
-1.0%ROA
Balance Sheet Health
Debt / Equity0.40x
Current Ratio4.58x
Net Debt$33.6M
Cash & Equivalents$326.2M
Quality Metrics
Altman Z-Score2.53
Piotroski F-Score5 / 9
FCF Margin16.1%
Rule of 4017.8
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $423M
Diluted EPS-$0.02TTMFY2025: $-0.01
Dividend
No dividend
Capital Allocation
Capex Intensity0.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Professional | $153.3M | +5.5% | |
| Specialty Retail | $130.4M | -8.3% | |
| Direct-To-Consumer | $139.3M | +3.1% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.